Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$34,252
in 1 filing

Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis Mark Steven −$34K Director sold 6% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-09-13 Capone Mark Christopher President & C.E.O. Grant or award +165,000 372,451
2017-09-13 LANCHBURY JERRY S Chief Scientific Officer Grant or award +50,000 157,034
2017-09-13 MARSH RICHARD M E.V.P., General Counsel Grant or award +50,000 155,729
2017-09-01 HENDERSON JOHN T Director Exercise or conversion +10,000 $16.46 $165K 52,524
2017-09-01 HENDERSON JOHN T Director Sale −10,000 $30.31 $303K 42,524
2017-09-01 HENDERSON JOHN T Director Exercise or conversion +10,000 $16.46 $165K 52,524
2017-09-01 HENDERSON JOHN T Director Sale −10,000 $30.30 $303K 42,524
2017-09-01 HENDERSON JOHN T Director Exercise or conversion +10,000 $16.46 $165K 52,524
2017-09-01 HENDERSON JOHN T Director Sale −10,000 $30.30 $303K 42,524
2017-09-01 HENDERSON JOHN T Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −10,000 20,000
2017-09-01 HENDERSON JOHN T Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −10,000 10,000
2017-09-01 HENDERSON JOHN T Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −10,000 0
2017-02-23 HENDERSON JOHN T Director Purchase +3,600 $18.58 $67K 42,124
2017-02-23 HENDERSON JOHN T Director Purchase +400 $18.57 $7K 42,524
2017-02-22 HENDERSON JOHN T Director Purchase +2,000 $18.81 $38K 38,524
2017-01-03 Tobin Bernard President Crescendo BioScience Returned to the company −2,631 $16.93 $45K 116,360
2016-12-01 Phanstiel S. Louise Director Grant or award +15,024 23,524
2016-12-01 DREISMANN HEINRICH Director Grant or award +15,024 32,524
2016-12-01 LANGER DENNIS Director Grant or award +15,024 32,524
2016-12-01 GILBERT WALTER PHD Director Grant or award +15,024 27,524

Page 47 of 60 · 1,194 trades